BioSpace News Archive

The digital care coordination solution provides better access to care for patients and improves efficiency across the group

This amazing development allows the cryptocurrency SAKURA BLOOM (SKB) to be used as compensation for people around the world who need state-of-the-art regenerative medicine technology to improve their lives” said President Takakazu Hirono of NEGTEC Co., Ltd.

Amgen (NASDAQ: AMGN) today announced the upcoming presentation of new Repatha® (evolocumab) analyses, including a late-breaking study evaluating the efficacy of Repatha in patients with metabolic syndrome and established cardiovascular disease at the ESC Congress 2018, organized by the European Society of Cardiology, in Munich, Aug. 25-29.

Distinctive graduate program ranked among the best in academic quality, affordability, and online programming

Dash Genomics announced the public launch of its platform for offering a personalized, genetic-based analysis for Alzheimer’s disease risk that is based on cutting edge research.

Initiation of enrollment in Part B of the ASCEND trial

Further to the release dated August 16, 2018 concerning the acquisition of a sixty percent (60%) interest in Santa Marta Golden Hemp S.A.S. (“SMGH”), Avicanna Inc. (“Avicanna” or the “Company”) is pleased to set out the details surrounding the acquisition of the SMGH shares and relationship with El Grupo Daabon (“Daabon”).

Company Recognized for Efforts to Expand Access to Oral Health Care for Underserved Populations Around the World

Sensei Biotherapeutics, Inc. announced the appointment of Ildiko Csiki, M.D., Ph.D., as Chief Medical Officer.

DoctorLogic ranks 317 out of 5,000 fastest-growing private companies with a total growth of more than 1,500% since its launch.